TALLARIGO LORENZO

CIK 00012760392 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001276039

Recent Transactions

48 trades

Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-07-07$9.82/sh+2,000→ 2,000 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2014-07-07−2,000→ 4,923 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-07-07$244.00/sh−1,000→ 0 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-07-07$242.11/sh−1,000→ 1,000 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-02-10$354.52/sh−368→ 1,640 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Restricted Stock Units
2014-02-09−368→ 735 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-02-09+368→ 2,008 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-01-07$67.41/sh−1,839→ 1,640 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2013-11-09+368→ 3,479 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Restricted Stock Units
2013-11-09−368→ 1,103 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2013-10-21$62.50/sh−124,912→ 5,938,890 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2013-10-15$62.50/sh−1,123,415→ 6,063,802 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2013-10-10+1,471→ 3,111 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Restricted Stock Units
2013-10-10−1,471→ 1,471 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Options to Purchase Common Stock
2013-05-07+2,450→ 2,450 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2013-05-07+1,640→ 1,640 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Restricted Stock Units
2012-11-16+2,942→ 2,942 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Options to Purchase Common Stock
2012-11-16+4,673→ 4,673 total
Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
2012-10-16+2,403,837→ 6,408,374 total
Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
2012-10-16+778,843→ 7,187,217 total
Conversion
INTERCEPT PHARMACEUTICALS, INC.
Series C Preferred Stock
2012-10-16−4,500,000→ 0 total
Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share
2012-10-16+2,403,837→ 4,004,537 total
Conversion
INTERCEPT PHARMACEUTICALS, INC.
Series A Preferred Stock
2012-10-16−13,888,889→ 0 total
Conversion
INTERCEPT PHARMACEUTICALS, INC.
Series B Preferred Stock
2012-10-16−13,888,889→ 0 total
Purchase
INTERCEPT PHARMACEUTICALS, INC.
Series C Preferred Stock
2012-08-09$2.00/sh+4,500,000→ 4,500,000 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Options to Purchase Common Stock
2012-07-31+4,326→ 4,326 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2008-03-24$49.84/sh−2,043→ 74,062 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2008-02-01$51.52/sh−6,304→ 86,105 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2007-11-30$52.79/sh−1,626→ 68,899 total
Sale
ELI LILLY & Co$LLY
Common Stock
2007-06-01$58.73/sh−4,533→ 75,058 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2007-02-01$54.12/sh−4,214→ 84,124 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2006-07-14$54.88/sh−1,543→ 66,127 total
Exercise/Conversion
ELI LILLY & Co$LLY
Employee stock option 10/95 (right to buy)
2005-07-01−2,000→ 0 total
Exercise/Conversion
ELI LILLY & Co$LLY
Common Stock
2005-07-01$23.41/sh+2,000→ 58,715 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2005-07-01$55.71/sh−1,199→ 57,516 total
Exercise/Conversion
ELI LILLY & Co$LLY
Employee stock option 10/95 (right to buy)
2005-06-01−2,000→ 2,000 total
Exercise/Conversion
ELI LILLY & Co$LLY
Common Stock
2005-06-01$23.41/sh+2,000→ 57,889 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2005-06-01$58.30/sh−1,174→ 56,715 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2005-05-02$58.47/sh−1,171→ 55,889 total
Exercise/Conversion
ELI LILLY & Co$LLY
Common Stock
2005-05-02$23.41/sh+2,000→ 57,060 total
Exercise/Conversion
ELI LILLY & Co$LLY
Employee stock option 10/95 (right to buy)
2005-05-02−2,000→ 4,000 total
Award
ELI LILLY & Co$LLY
Employee stock option (right to buy)
2005-02-11+53,254→ 53,254 total
Exercise/Conversion
ELI LILLY & Co$LLY
Employee stock option (right to buy)
2005-02-03−2,000→ 10,000 total
Exercise/Conversion
ELI LILLY & Co$LLY
Common Stock
2005-02-03$23.41/sh+2,000→ 56,299.36 total
Award
ELI LILLY & Co$LLY
Common Stock
2005-01-14$56.79/sh+5,600→ 54,299.36 total
Award
ELI LILLY & Co$LLY
Common Stock
2004-12-20+15,000→ 48,699.36 total
Exercise/Conversion
ELI LILLY & Co$LLY
Employee stock option (right to buy)
2004-10-14−12,000→ 0 total
Exercise/Conversion
ELI LILLY & Co$LLY
Common Stock
2004-10-14$14.66/sh+12,000→ 33,699.36 total

Companies

Recent Filings

Address

C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET

NEW YORK, NY, 10013

View on SEC.gov